ATLAS Biolabs GmbH Has Licensed Cartagenia n.v. Software for Analysis and Interpretation of Genetic Data
"We are delighted with this new software,“ said Dr. Karsten Heidtke, Head of Bioinformatics at ATLAS Biolabs. ”The advantages for our customers are obvious. It provides them with an efficient evaluation system on which they can rely without having to establish their own bioinformatics resources. Cartagenia BENCH processes DNA data from all common chip assay systems including Affymetrix, Agilent and NimbleGen, which are handled at ATLAS Biolabs."
In addition to academic institutions, centers specialized in human genetic testing and cytogenetic laboratories may benefit particularly from ATLAS Biolabs’ new service. “In a pilot phase, hundreds of results have already been transferred to the Cartagenia BENCH platform. This tremendously improves our capacity to compare common genetic elements between patients with identical phenotypes," explains Dr. Gundula Thiel, Medical Director of ATLAS Biolabs GmbH and head of a human genetic laboratory in Berlin, Germany.
ATLAS Biolabs has licensed Cartagenia software for analysis and interpretation of genetic data
ATLAS Biolabs GmbH
ATLAS Biolabs GmbH is a leading provider of complex analyses in molecular genetics, including microarray-based genomic services, targeted sequence capture and next- generation sequencing in Europe. The company has access to the DNA chip platforms of all leading enterprises in this field (Affymetrix, Agilent, Illumina, and NimbleGen) and is a Certified Affymetrix, Agilent and NimbleGen Service Provider. The German company was founded in 2006. Customers of ATLAS Biolabs include academic institutions, pharmaceutical and biotechnological enterprises as well as clinicians and registered doctors both in Germany and abroad. For more information please access www.atlas- biolabs.com.
Cartagenia
Cartagenia delivers diagnostic knowledge, software and database systems and services to enable genetic labs and clinicians to perform clinically relevant genetic analyses quickly and efficiently, allowing them to offer patients and carers high quality genetic interpretation and counseling.
Cartagenia BENCH gives genetic labs and clinics the tools to optimize their analysis and diagnostic offering, and accelerate their routine diagnostic workflow. With BENCH, genetic labs and clinicians can perform clinically relevant genetic analyses faster, more precisely and more cost-efficiently. Labs and clinics can share precious case material and experience with total confidence, and use both public and internally built knowledge in their diagnostic setting. With Cartagenia BENCH, the large number of findings from genetic screens become interpretable and understandable. BENCH helps clinical geneticists, lab technicians, and genetic counselors to manage, analyze, visualize and interpret results from various genetic screening assays, from array CGH over locus- specific screening to next generation sequencing platforms. For more information please access www.cartagenia.com.
Contact: Mugele Kommunikation Dr. Katrin Mugele Phone: + 49 30 7816869 Fax: + 49 3212 7816869 E-mail: press@mugele-kommunikation.de
ATLAS Biolabs GmbH Friedrichstr. 147 | 10117 Berlin, Germany Registered Office: Cologne, Germany Commercial Register: Amtsgericht Köln | HRB 59119 CEO: Prof. Dr. Peter Nürnberg www.atlas-biolabs.com
Cartagenia n.v. Technologielaan 3 | 3001 Leuven, Belgium Commercial Register: RPR Leuven | BE 0807 353 962 CEO: Herman Verrelst www.cartagenia.com